Jasper Hellweg
Stock Analyst at Argus Research
(3.44)
# 900
Out of 4,834 analysts
89
Total ratings
50.7%
Success rate
17.4%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Downgrades: Hold | n/a | $122.24 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $302.08 | +32.42% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $80.37 | +86.64% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $50.41 | +19.02% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $582.80 | +100.75% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $432.78 | +27.09% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $67.86 | +25.26% | 3 | May 30, 2024 | |
| NVO Novo Nordisk | Maintains: Buy | $115 → $125 | $66.01 | +89.37% | 1 | Feb 1, 2024 | |
| MRNA Moderna | Maintains: Buy | $160 → $140 | $23.33 | +500.09% | 4 | Sep 13, 2023 | |
| ABBV AbbVie | Downgrades: Hold | n/a | $179.71 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $200 | $158.79 | +25.95% | 6 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $17.02 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $139.89 | +107.31% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $119.72 | -16.47% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $245.65 | +20.09% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.46 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $175.05 | -22.88% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $30.66 | - | 2 | Sep 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $26.31 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $273.89 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $104.35 | - | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $43.16 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $378.91 | -59.09% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $159.82 | -43.69% | 1 | Sep 19, 2018 |
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $122.24
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $302.08
Upside: +32.42%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $80.37
Upside: +86.64%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $50.41
Upside: +19.02%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $582.80
Upside: +100.75%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $432.78
Upside: +27.09%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $67.86
Upside: +25.26%
Novo Nordisk
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $66.01
Upside: +89.37%
Moderna
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $23.33
Upside: +500.09%
AbbVie
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $179.71
Upside: -
Jun 17, 2022
Maintains: Buy
Price Target: $225 → $200
Current: $158.79
Upside: +25.95%
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $17.02
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $139.89
Upside: +107.31%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $119.72
Upside: -16.47%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $245.65
Upside: +20.09%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $5.46
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $175.05
Upside: -22.88%
Sep 4, 2020
Downgrades: Hold
Price Target: n/a
Current: $30.66
Upside: -
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $26.31
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $273.89
Upside: -
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $104.35
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $43.16
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $378.91
Upside: -59.09%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $159.82
Upside: -43.69%